Create Alert
Watchlist

Mercury Labs

₹849.95
+14.45 (1.73%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
820.00
Prev. Close
835.50
Volume
90
Total traded value
0.01 Cr
Upper Circuit
877.25
Lower Circuit
793.75

Fundamentals

Market Cap₹100Cr
ROE8.81%
P/E Ratio(TTM)20.40
EPS(TTM)40.95
P/B Ratio1.80
Dividend Yield0.42%
Industry P/E40.32
Book Value464.65
Debt to Equity0.11
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Mercury Labs

Established in 1962, Mercury Laboratories is a leading pharmaceutical company specializing in formulating and developing high-quality medicines for a wide range of therapeutic needs. The company's primary mission is to improve the quality of life for patients by providing them with safe, effective, and accessible medicines. Quality is central to its operations, with state-of-the-art manufacturing facilities adhering to stringent Good Manufacturing Practices (GMP) and equipped with advanced technology. Innovation is a key success driver, as the company constantly explores new formulation technologies and delivery systems to enhance its medicines' effectiveness. With a special dedication to Mother & Child Healthcare, the company has built a strong reputation for excellence in pharmaceutical formulation and patient care. Mercury Laboratories has a strong presence in both domestic and international markets, exporting products to over 40 countries worldwide.;
Parent OrganisationMercury Labs Limited
Managing DirectorMr. Rajendra R Shah
Founded1962
BSE Symbol538964

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
73.66%
Retail And Others
26.34%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
58.80
Ajanta Pharma
NA
(0.00%)
33.44
Gland Pharma
NA
(0.00%)
36.89
Eris Lifesciences
NA
(0.00%)
47.39